BRPI1013336A2 - novos solvatos de cristais - Google Patents
novos solvatos de cristaisInfo
- Publication number
- BRPI1013336A2 BRPI1013336A2 BRPI1013336A BRPI1013336A BRPI1013336A2 BR PI1013336 A2 BRPI1013336 A2 BR PI1013336A2 BR PI1013336 A BRPI1013336 A BR PI1013336A BR PI1013336 A BRPI1013336 A BR PI1013336A BR PI1013336 A2 BRPI1013336 A2 BR PI1013336A2
- Authority
- BR
- Brazil
- Prior art keywords
- new crystal
- crystal solvates
- solvates
- new
- crystal
- Prior art date
Links
- 239000013078 crystal Substances 0.000 title 1
- 239000012453 solvate Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4178—1,3-Diazoles not condensed 1,3-diazoles and containing further heterocyclic rings, e.g. pilocarpine, nitrofurantoin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing aromatic rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2009109160 | 2009-04-28 | ||
| PCT/JP2010/057404 WO2010126014A1 (ja) | 2009-04-28 | 2010-04-27 | 新規溶媒和物結晶 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| BRPI1013336A2 true BRPI1013336A2 (pt) | 2016-03-29 |
| BRPI1013336B1 BRPI1013336B1 (pt) | 2020-02-04 |
Family
ID=43032159
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BRPI1013336A BRPI1013336B1 (pt) | 2009-04-28 | 2010-04-27 | cristais solvatos de acetona, métodos para produção dos referidos cristais e método para produção de olmesartana medoxomila |
Country Status (19)
| Country | Link |
|---|---|
| US (2) | US8859600B2 (pt) |
| EP (1) | EP2426127B1 (pt) |
| JP (2) | JP5697593B2 (pt) |
| KR (1) | KR20120006513A (pt) |
| CN (1) | CN102414201B (pt) |
| AU (1) | AU2010242635A1 (pt) |
| BR (1) | BRPI1013336B1 (pt) |
| CA (1) | CA2760031C (pt) |
| CO (1) | CO6470817A2 (pt) |
| ES (1) | ES2753874T3 (pt) |
| IL (1) | IL215965A0 (pt) |
| MX (1) | MX2011011540A (pt) |
| MY (1) | MY158090A (pt) |
| NZ (1) | NZ596326A (pt) |
| RU (1) | RU2563631C2 (pt) |
| SG (2) | SG10201501131SA (pt) |
| TW (1) | TWI464162B (pt) |
| WO (1) | WO2010126014A1 (pt) |
| ZA (1) | ZA201107813B (pt) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2011021224A2 (en) * | 2009-08-19 | 2011-02-24 | Msn Laboratories Limited | Process for (5-methyl-2-oxo-1,3-dioxolen-4-yl)methyl4-(1-hydroxy-1-methylethyl)-2-propyl-1-[4-[2-tetrazol-5-yl)phenyl]phenyl]methylimidazole-5-carboxylate |
| CN103214469B (zh) * | 2013-04-29 | 2014-12-10 | 孙威 | 一种奥美沙坦酯化合物及其制备方法 |
| CN107474042A (zh) * | 2017-09-07 | 2017-12-15 | 浙江华海致诚药业有限公司 | 一种三苯甲基奥美沙坦酯的晶型h |
| CN110082449B (zh) * | 2019-05-24 | 2020-05-19 | 珠海润都制药股份有限公司 | 一种奥美沙坦酯中三苯基氯甲烷的检测方法 |
| CN113105439A (zh) * | 2021-04-15 | 2021-07-13 | 迪嘉药业集团有限公司 | 一种小粒度奥美沙坦酯的结晶制备方法 |
| CN116217628B (zh) * | 2023-05-08 | 2023-07-14 | 华东理工常熟研究院有限公司 | 奥沙利铂Pt(IV)配合物的共晶及其制备方法 |
Family Cites Families (29)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH0282519A (ja) | 1988-09-19 | 1990-03-23 | Sanyo Electric Co Ltd | 固相エピタキシャル成長方法 |
| US5616599A (en) | 1991-02-21 | 1997-04-01 | Sankyo Company, Limited | Angiotensin II antagosist 1-biphenylmethylimidazole compounds and their therapeutic use |
| CA2229000C (en) | 1991-02-21 | 2002-04-09 | Sankyo Company, Limited | 1-biphenylimidazole derivatives, their preparation and their therapeutic use |
| JPH0753489A (ja) * | 1993-06-11 | 1995-02-28 | Sankyo Co Ltd | ビフェニルカルボキサミド誘導体の製造法 |
| JPH07121918A (ja) | 1993-08-30 | 1995-05-12 | Tdk Corp | 光磁気記録媒体 |
| JP3671266B2 (ja) | 1996-03-21 | 2005-07-13 | 東洋化成工業株式会社 | ５−置換テトラゾール類の製造方法 |
| JP3521304B2 (ja) | 1996-03-21 | 2004-04-19 | 東洋化成工業株式会社 | １−（テトラゾリルビフェニルメチル）イミダゾール誘導体の製造方法 |
| CO4940418A1 (es) | 1997-07-18 | 2000-07-24 | Novartis Ag | Modificacion de cristal de un derivado de n-fenil-2- pirimidinamina, procesos para su fabricacion y su uso |
| IT1295405B1 (it) * | 1997-09-30 | 1999-05-12 | Merck Sharp & Dohme Italia S P | Uso di un antagonista recettoriale di angiotensina ii per la preparazione di farmaci per aumentare il tasso di sopravvivenza di |
| JP2004217542A (ja) | 2003-01-10 | 2004-08-05 | Fuji Photo Film Co Ltd | ４，５−ジアルコキシカルボニルイミダゾールの製造方法 |
| US20070054948A1 (en) | 2004-09-02 | 2007-03-08 | Lilach Hedvati | Purification of olmesartan medoxomil |
| WO2006029056A1 (en) | 2004-09-02 | 2006-03-16 | Teva Pharmaceutical Industries Ltd. | Preparation of olmesartan medoxomil |
| KR20090102883A (ko) | 2004-09-02 | 2009-09-30 | 테바 파마슈티컬 인더스트리즈 리미티드 | 올메살탄 메독소밀의 정제 |
| JP2006111586A (ja) | 2004-10-15 | 2006-04-27 | Nippon Petrochemicals Co Ltd | 置換芳香族化合物の酸化方法 |
| JP2007526342A (ja) | 2005-01-03 | 2007-09-13 | テバ ファーマシューティカル インダストリーズ リミティド | 低レベルの不純物を有するオルメサルタンメドキソミル |
| CA2616466A1 (en) | 2005-07-29 | 2007-02-15 | Krka | Process for the preparation of olmesartan medoxomil |
| SI22092A (sl) * | 2005-07-29 | 2007-02-28 | Krka, Tovarna Zdravil, D.D., Novo Mesto | Postopek za pripravo olmesartan medoksomila |
| WO2007047838A2 (en) | 2005-10-20 | 2007-04-26 | Dr. Reddy's Laboratories Ltd. | Process for preparing olmesartan medoxomil |
| CZ299902B6 (cs) | 2005-10-27 | 2008-12-29 | Zentiva, A. S | Zpusob odstranování trifenylmethanové chránicí skupiny u prekurzoru antihypertenzních léciv |
| WO2007148344A2 (en) * | 2006-06-19 | 2007-12-27 | Matrix Laboratories Limited | Process for the preparation of olmesartan medoxomil |
| ITMI20061848A1 (it) | 2006-09-27 | 2008-03-28 | Dipharma Spa | Procedimento per la preparazione di composti feniltetrazolici |
| KR101458369B1 (ko) | 2006-10-09 | 2014-11-05 | 씨아이피엘에이 엘티디. | 트리틸 올메사탄 메독소밀 및 올메사탄 메독소밀의 제조방법 |
| EP2036904A1 (en) * | 2007-08-08 | 2009-03-18 | LEK Pharmaceuticals D.D. | A process for the preparation of olmesartan medoxomil |
| ATE528305T1 (de) * | 2007-08-08 | 2011-10-15 | Lek Pharmaceuticals | Verfahren zur herstellung oder reinigung von olmesartan-medoxomil oder von olmesartan- medoxomil-hydrohalid-salz |
| EP2298763B1 (en) | 2008-06-09 | 2015-03-25 | Daiichi Sankyo Company, Limited | Method for producing 1-biphenylmethylimidazole compound |
| SI2334668T1 (sl) | 2008-09-05 | 2014-08-29 | Krka, Tovarna Zdravil D.D., Novo Mesto | Postopek priprave intermediata olmesartan medoksomila |
| CA2759163C (en) * | 2009-04-28 | 2015-02-17 | Daiichi Sankyo Company, Limited | Method for producing olmesartan medoxomil |
| WO2011014611A2 (en) | 2009-07-30 | 2011-02-03 | Dr. Reddy's Laboratories Ltd. | Preparation of olmesartan medoxomil |
| WO2012001694A1 (en) | 2010-06-28 | 2012-01-05 | Hetero Research Foundation | Process for olmesartan medoxomil |
-
2010
- 2010-04-27 US US13/266,967 patent/US8859600B2/en active Active
- 2010-04-27 MY MYPI2011005182A patent/MY158090A/en unknown
- 2010-04-27 NZ NZ596326A patent/NZ596326A/en not_active IP Right Cessation
- 2010-04-27 MX MX2011011540A patent/MX2011011540A/es active IP Right Grant
- 2010-04-27 RU RU2011148101/04A patent/RU2563631C2/ru not_active IP Right Cessation
- 2010-04-27 JP JP2011511396A patent/JP5697593B2/ja active Active
- 2010-04-27 KR KR1020117025160A patent/KR20120006513A/ko not_active Ceased
- 2010-04-27 EP EP10769712.0A patent/EP2426127B1/en active Active
- 2010-04-27 SG SG10201501131SA patent/SG10201501131SA/en unknown
- 2010-04-27 ES ES10769712T patent/ES2753874T3/es active Active
- 2010-04-27 TW TW099113167A patent/TWI464162B/zh active
- 2010-04-27 BR BRPI1013336A patent/BRPI1013336B1/pt active IP Right Grant
- 2010-04-27 SG SG2011077146A patent/SG175296A1/en unknown
- 2010-04-27 WO PCT/JP2010/057404 patent/WO2010126014A1/ja not_active Ceased
- 2010-04-27 CA CA2760031A patent/CA2760031C/en active Active
- 2010-04-27 AU AU2010242635A patent/AU2010242635A1/en not_active Abandoned
- 2010-04-27 CN CN201080018900.9A patent/CN102414201B/zh active Active
-
2011
- 2011-10-25 ZA ZA2011/07813A patent/ZA201107813B/en unknown
- 2011-10-26 IL IL215965A patent/IL215965A0/en unknown
- 2011-11-24 CO CO11161167A patent/CO6470817A2/es not_active Application Discontinuation
-
2014
- 2014-10-14 US US14/513,984 patent/US20160102079A1/en not_active Abandoned
-
2015
- 2015-01-08 JP JP2015002227A patent/JP5944539B2/ja active Active
Also Published As
| Publication number | Publication date |
|---|---|
| JP5944539B2 (ja) | 2016-07-05 |
| CN102414201A (zh) | 2012-04-11 |
| IL215965A0 (en) | 2012-01-31 |
| RU2563631C2 (ru) | 2015-09-20 |
| AU2010242635A2 (en) | 2014-08-07 |
| SG10201501131SA (en) | 2015-04-29 |
| KR20120006513A (ko) | 2012-01-18 |
| MY158090A (en) | 2016-08-30 |
| ZA201107813B (en) | 2012-07-25 |
| RU2011148101A (ru) | 2013-06-10 |
| ES2753874T3 (es) | 2020-04-14 |
| JP5697593B2 (ja) | 2015-04-08 |
| CA2760031C (en) | 2015-03-10 |
| SG175296A1 (en) | 2011-11-28 |
| EP2426127A1 (en) | 2012-03-07 |
| CO6470817A2 (es) | 2012-06-29 |
| JP2015071647A (ja) | 2015-04-16 |
| US20120059172A1 (en) | 2012-03-08 |
| US8859600B2 (en) | 2014-10-14 |
| US20160102079A1 (en) | 2016-04-14 |
| CN102414201B (zh) | 2015-10-14 |
| TWI464162B (zh) | 2014-12-11 |
| NZ596326A (en) | 2014-02-28 |
| EP2426127B1 (en) | 2019-09-04 |
| BRPI1013336B1 (pt) | 2020-02-04 |
| EP2426127A4 (en) | 2012-10-03 |
| AU2010242635A1 (en) | 2011-12-01 |
| WO2010126014A1 (ja) | 2010-11-04 |
| JPWO2010126014A1 (ja) | 2012-11-01 |
| CA2760031A1 (en) | 2010-11-04 |
| TW201043616A (en) | 2010-12-16 |
| MX2011011540A (es) | 2012-04-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| LTPA2018008I1 (lt) | Kristalai | |
| EP2503013A4 (en) | HEAT-RESISTANT SUPER ALLOY | |
| BRPI1007450A2 (pt) | dispositivo de exibição | |
| BRPI1013318A2 (pt) | dispositivo de exibição | |
| BRPI0924840A2 (pt) | dispositivo de exibição | |
| FI20095302A0 (fi) | Luminesenssimääritysmenetelmä | |
| BRPI1008827A2 (pt) | deisobutenizador | |
| BR112012000657A2 (pt) | novos azabicilohexanos | |
| BR112012004964A2 (pt) | girocóptero | |
| BRPI1008070A2 (pt) | tricianoboratos | |
| BR112012000040A2 (pt) | dispositivo de exibição | |
| DE112010003255A5 (de) | Fördergutverteiler | |
| BR112012005432A2 (pt) | dispositivo de exibição | |
| EP2477076A4 (en) | FIXING DEVICE | |
| FR2953228B1 (fr) | Ecran pare-pierres | |
| DK2267242T3 (da) | Udskiftningskonsol | |
| BRPI1011789A2 (pt) | dispositivo de exibição | |
| BR112012006693A2 (pt) | combinação | |
| BR112012003630A2 (pt) | dispositivo de exibição | |
| BR112012003616A2 (pt) | metilpirroloprimidinacarboxamidas | |
| FR2949653B1 (fr) | Presentoir pour protege-cahier | |
| FI9569U1 (fi) | Sisustuselementti | |
| BR112012006968A2 (pt) | combinação | |
| DK2408293T3 (da) | Hoved-krop-børsteindretning | |
| BRPI1008205A2 (pt) | dispositivo de exibição |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] | ||
| B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
| B07E | Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette] | ||
| B06T | Formal requirements before examination [chapter 6.20 patent gazette] | ||
| B07A | Application suspended after technical examination (opinion) [chapter 7.1 patent gazette] | ||
| B09A | Decision: intention to grant [chapter 9.1 patent gazette] | ||
| B16A | Patent or certificate of addition of invention granted [chapter 16.1 patent gazette] |
Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 27/04/2010, OBSERVADAS AS CONDICOES LEGAIS. |